Coronavirus (Covid-19) Infection Survey Northern Ireland – 30 May To 5 June 2021

Date published: 11 June 2021

The Department of Health today published the next in the series of weekly results from its COVID-19 Infection Survey (CIS).

covid latest stats

The findings set out in this report relate to modelled positivity estimates for Northern Ireland for the week up to the 5 June 2021. The aims of the CIS are to estimate how many people have the infection and the number of new cases that occur over a given time as well as estimating how many people have developed antibodies to COVID-19.

The survey over time will help track the extent of infection and transmission of COVID-19 among people in the community population (those in private residences).

Key Findings

Due to the relatively small number of tests and positive swab results within our sample, credible intervals are wide and therefore results should be interpreted with caution.

  • During the most recent week of the study (30 May – 5 June), it is estimated that 2,600 people in Northern Ireland had COVID-19 (95% credible interval: 1,000 to 5,200). 
  • This equates to 0.14% of the population (95% credible interval: 0.05% to 0.28%) or around 1 in 700 people (95% credible interval 1 in 1,890 to 1 in 350).
  • Modelling suggests the trend in the percentage of people testing positive is uncertain in the most recent week in Northern Ireland however infection rates remain low compared with earlier months in the year.
  • In the latest six-week period, there were 15,967 swab tests taken in total from 10,825 participants. Of these, 15 participants tested positive from 15 different households.
  • In the latest two-week period, of the 5,363 participants in the study, 6 tested positive from 6 households.
  • Due to lower positivity rates, incidence rates have not been updated. The methods and survey design are regularly reviewed as part of the ongoing quality assurance process. The incidence method uses several weeks’ data to provide the latest estimate of new infections. Due to lower numbers of people testing positive over the last several weeks compared with earlier in the year, the estimates of incidence are being reviewed (last published 7 May 2021). This review ensures that the estimates provided continue to be of high quality.

New variant analysis

A new variant of the coronavirus (COVID-19) was identified in the UK in mid-November 2020. The Alpha variant (B.1.1.7, previously known as the UK variant) of COVID-19 has changes in one of the three genes which coronavirus swab tests detect, known as the S-gene. This means in cases compatible with the Alpha (UK) variant, the S-gene is no longer detected by the current test. While there are other reasons why a positive swab test may not detect the S-gene, absence of the S-gene has become a reliable indicator of the Alpha (UK) variant in COVID-19.

Other variants, including B.1.525 (WHO ‘Eta’; first identified in Nigeria), may also have this same pattern of gene positivity. At present these are rare in the UK so this group will continue to be described as compatible with the Alpha (UK) variant, but this will continue to be reviewed.

In contrast other variants of concern including both B.1.617.2 (WHO ‘Delta’; first detected in India) and B.1.351 (WHO ‘Beta’; first detected in South Africa) have an S-gene that is detectable with the current test and will therefore be included in the “not compatible with Alpha (UK) variant” group of COVID-19 where the virus level is high enough to identify this. It is not possible to further differentiate within each group of variants (with the same gene pattern) by swab PCR test alone. You can read more about the Alpha (UK) variant in the Office for National Statistics blog.

For cases compatible with Alpha (i.e. UK variant), cases not compatible with Alpha and cases where the virus is too low to be identifiable, the trend remains uncertain in the most recent week in Northern Ireland.

It should be noted that there is considerable uncertainty around these estimates due to the small numbers of UK variant compatible positives detected in Northern Ireland and also given that not all cases that are positive on the ORF1ab and N-genes will be the UK variant.

Notes to editors: 

  1. The Department of Health has been working along with the Public Health Agency, Northern Ireland Statistics and Research Agency and the Office for National Statistics (and its various survey partners) to extend the COVID-19 Infection Survey to Northern Ireland. Fieldwork in Northern Ireland began on 27 July 2020.
  2. All results are provisional and subject to revision. Due to relatively small number of tests and positive swab tests within the sample, credible intervals are wide and therefore results should be interpreted with caution.
  3. These statistics refer to infections reported in the community (i.e. private households). These figures exclude infections reported in hospitals, care homes and/or other institutional settings.
  4. Estimates of the total national proportion of the population testing positive for COVID-19 are adjusted to be representative of the population of Northern Ireland that live in private residential households in terms of age, sex and region.
  5. Weekly reports are to be published with findings from the COVID-19 Infection survey. It is anticipated that new and further analyses will be added to the weekly reports over time.
  6. Further information about quality and methodology associated with the survey can be found on the ONS
  7. This publication is available online.
  8. Additional information is available from:
    Information Analysis Directorate
    Department of Health
    Annex 2, Castle Buildings
    Belfast BT4 3SQ
    Telephone: 028 9052 2340       
  9. For media enquiries please contact the DoH Press Office by email
  10. Follow us on Twitter @healthdpt.
  11. The Executive Information Service operates an out of hours service For Media Enquiries Only between 1800hrs and 0800hrs Monday to Friday and at weekends and public holidays. The duty press officer can be contacted on 028 9037 8110.

Share this page

Back to top